Mitsubishi UFJ Asset Management Co. Ltd. Has $383.42 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 857,315 shares of the medical equipment provider’s stock after purchasing an additional 39,433 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Intuitive Surgical were worth $383,417,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Tobam increased its position in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC acquired a new position in Intuitive Surgical in the 2nd quarter worth approximately $27,000. Greykasell Wealth Strategies Inc. purchased a new position in Intuitive Surgical during the 3rd quarter worth approximately $27,000. Guerra Advisors Inc purchased a new position in Intuitive Surgical during the 3rd quarter worth approximately $37,000. Finally, Riggs Asset Managment Co. Inc. raised its stake in Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after purchasing an additional 32 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, Director Gary S. Guthart sold 24,500 shares of the business’s stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total value of $12,987,450.00. Following the completion of the sale, the director directly owned 3,694 shares in the company, valued at approximately $1,958,189.40. The trade was a 86.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 4,500 shares of the company’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the sale, the senior vice president directly owned 907 shares of the company’s stock, valued at approximately $496,455.52. This represents a 83.23% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 56,189 shares of company stock worth $30,785,441. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $506.17 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The stock’s 50-day moving average is $532.31 and its two-hundred day moving average is $511.29. The firm has a market cap of $179.76 billion, a P/E ratio of 64.15, a price-to-earnings-growth ratio of 3.83 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the prior year, the company posted $2.21 EPS. The firm’s revenue was up 18.8% on a year-over-year basis. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of research analyst reports. TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Robert W. Baird decreased their price objective on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research report on Friday, January 23rd. The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a research note on Friday, January 9th. UBS Group set a $570.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research report on Tuesday. Finally, Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research report on Friday, December 12th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $615.86.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.